Literature DB >> 32524278

Proton Pump Inhibitors in Children: the Good, the Bad, and the Ugly.

Eric A Pasman1,2, Bruce Ong1,3, Claire P Witmer1,2, Cade M Nylund4,5.   

Abstract

PURPOSE OF REVIEW: The evidence supporting or contesting the prescription of proton pump inhibitors (PPIs) for children and updates on side effects are reviewed. RECENT
FINDINGS: PPIs remain an important therapeutic option for esophagitis and gastritis. However, recent studies demonstrate no benefit when prescribing PPIs for chronic cough, infantile reflux, asthma, or functional gastrointestinal disorders. Recent studies suggest adverse effects on microbiome diversity and immune function, resulting in increased rates of gastrointestinal infections, bone fractures, and atopic disorders. PPIs influence a variety of cell types within the in the innate and adaptive immune systems. PPI prescriptions in children may be indicated for select conditions; however, multiple side effects and immune effects have been described. While most of these side effects are rare and mild, some studies suggest enduring adverse effects. Future studies to elucidate the mechanism behind some of these immune and infectious complications will be beneficial.

Entities:  

Keywords:  Allergy; Children; Immunology; Proton pump inhibitor; Side effects

Mesh:

Substances:

Year:  2020        PMID: 32524278     DOI: 10.1007/s11882-020-00926-4

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  4 in total

Review 1.  A Narrative Review on Efficacy and Safety of Proton Pump Inhibitors in Children.

Authors:  Valeria Dipasquale; Giuseppe Cicala; Edoardo Spina; Claudio Romano
Journal:  Front Pharmacol       Date:  2022-02-10       Impact factor: 5.810

Review 2.  An Overview on Different L-Thyroxine (l-T4) Formulations and Factors Potentially Influencing the Treatment of Congenital Hypothyroidism During the First 3 Years of Life.

Authors:  Stefano Stagi; Giovanna Municchi; Marta Ferrari; Malgorzata Gabriela Wasniewska
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-09       Impact factor: 6.055

3.  A 10-year retrospective observational study on the utility and prescription standards of dexamethasone in pediatric neuro-oncosurgery in a tertiary care center.

Authors:  Anutra Chumbala Na Ayudhaya; Scott R Morrison; Chandrasekaran Kaliaperumal; Pasquale Gallo
Journal:  Childs Nerv Syst       Date:  2022-06-08       Impact factor: 1.532

4.  A Novel In Vitro Model for Determining the Optimum pH and Dose Volume of New Liquid Alginate for Infant Reflux Suppression.

Authors:  Jeanine Fisher; Fiona McLaughlin; Neil Fawkes; Hannah Tipple; Cathal Coyle; Peter W Dettmar
Journal:  Drugs R D       Date:  2021-07-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.